Deep learning has demonstrated remarkable achievements in medical image segmentation. However, prevailing deep learning models struggle with poor generalization due to (i) intra-class variations, where the same class appears differently in different samples, and (ii) inter-class independence, resulting in difficulties capturing intricate relationships between distinct objects, leading to higher false negative cases. This paper presents a novel approach that synergies spatial and spectral representations to enhance domain-generalized medical image segmentation. We introduce the innovative Spectral Correlation Coefficient objective to improve the model's capacity to capture middle-order features and contextual long-range dependencies. This objective complements traditional spatial objectives by incorporating valuable spectral information. Extensive experiments reveal that optimizing this objective with existing architectures like UNet and TransUNet significantly enhances generalization, interpretability, and noise robustness, producing more confident predictions. For instance, in cardiac segmentation, we observe a 0.81 pp and 1.63 pp (pp = percentage point) improvement in DSC over UNet and TransUNet, respectively. Our interpretability study demonstrates that, in most tasks, objectives optimized with UNet outperform even TransUNet by introducing global contextual information alongside local details. These findings underscore the versatility and effectiveness of our proposed method across diverse imaging modalities and medical domains.

This study presents an innovative approach for automatic road detection with deep learning, by employing fusion strategies for utilizing both lower-resolution satellite imagery and GPS trajectory data, a concept never explored before. We rigorously investigate both early and late fusion strategies, and assess deep learning based road detection performance using different fusion settings. Our extensive ablation studies assess the efficacy of our framework under diverse model architectures, loss functions, and geographic domains (Istanbul and Montreal). For an unbiased and complete evaluation of road detection results, we use both region-based and boundary-based evaluation metrics for road segmentation. The outcomes reveal that the ResUnet model outperforms U-Net and D-Linknet in road extraction tasks, achieving superior results over the benchmark study using low-resolution Sentinel-2 data. This research not only contributes to the field of automatic road detection but also offers novel insights into the utilization of data fusion methods in diverse applications.

Domain generalization aims to train models on multiple source domains so that they can generalize well to unseen target domains. Among many domain generalization methods, Fourier-transform-based domain generalization methods have gained popularity primarily because they exploit the power of Fourier transformation to capture essential patterns and regularities in the data, making the model more robust to domain shifts. The mainstream Fourier-transform-based domain generalization swaps the Fourier amplitude spectrum while preserving the phase spectrum between the source and the target images. However, it neglects background interference in the amplitude spectrum. To overcome this limitation, we introduce a soft-thresholding function in the Fourier domain. We apply this newly designed algorithm to retinal fundus image segmentation, which is important for diagnosing ocular diseases but the neural network's performance can degrade across different sources due to domain shifts. The proposed technique basically enhances fundus image augmentation by eliminating small values in the Fourier domain and providing better generalization. The innovative nature of the soft thresholding fused with Fourier-transform-based domain generalization improves neural network models' performance by reducing the target images' background interference significantly. Experiments on public data validate our approach's effectiveness over conventional and state-of-the-art methods with superior segmentation metrics.

In this study, we propose a new activation function, called Adaptive Smooth Activation Unit (ASAU), tailored for optimized gradient propagation, thereby enhancing the proficiency of convolutional networks in medical image analysis. We apply this new activation function to two important and commonly used general tasks in medical image analysis: automatic disease diagnosis and organ segmentation in CT and MRI. Our rigorous evaluation on the RadImageNet abdominal/pelvis (CT and MRI) dataset and Liver Tumor Segmentation Benchmark (LiTS) 2017 demonstrates that our ASAU-integrated frameworks not only achieve a substantial (4.80\%) improvement over ReLU in classification accuracy (disease detection) on abdominal CT and MRI but also achieves 1\%-3\% improvement in dice coefficient compared to widely used activations for `healthy liver tissue' segmentation. These improvements offer new baselines for developing a diagnostic tool, particularly for complex, challenging pathologies. The superior performance and adaptability of ASAU highlight its potential for integration into a wide range of image classification and segmentation tasks.

Knowledge distillation(KD) has demonstrated remarkable success across various domains, but its application to medical imaging tasks, such as kidney and liver tumor segmentation, has encountered challenges. Many existing KD methods are not specifically tailored for these tasks. Moreover, prevalent KD methods often lack a careful consideration of what and from where to distill knowledge from the teacher to the student. This oversight may lead to issues like the accumulation of training bias within shallower student layers, potentially compromising the effectiveness of KD. To address these challenges, we propose Hierarchical Layer-selective Feedback Distillation (HLFD). HLFD strategically distills knowledge from a combination of middle layers to earlier layers and transfers final layer knowledge to intermediate layers at both the feature and pixel levels. This design allows the model to learn higher-quality representations from earlier layers, resulting in a robust and compact student model. Extensive quantitative evaluations reveal that HLFD outperforms existing methods by a significant margin. For example, in the kidney segmentation task, HLFD surpasses the student model (without KD) by over 10pp, significantly improving its focus on tumor-specific features. From a qualitative standpoint, the student model trained using HLFD excels at suppressing irrelevant information and can focus sharply on tumor-specific details, which opens a new pathway for more efficient and accurate diagnostic tools.

With the advent of the IoT, AI, ML, and DL algorithms, the landscape of data-driven medical applications has emerged as a promising avenue for designing robust and scalable diagnostic and prognostic models from medical data. This has gained a lot of attention from both academia and industry, leading to significant improvements in healthcare quality. However, the adoption of AI-driven medical applications still faces tough challenges, including meeting security, privacy, and quality of service (QoS) standards. Recent developments in \ac{FL} have made it possible to train complex machine-learned models in a distributed manner and have become an active research domain, particularly processing the medical data at the edge of the network in a decentralized way to preserve privacy and address security concerns. To this end, in this paper, we explore the present and future of FL technology in medical applications where data sharing is a significant challenge. We delve into the current research trends and their outcomes, unravelling the complexities of designing reliable and scalable \ac{FL} models. Our paper outlines the fundamental statistical issues in FL, tackles device-related problems, addresses security challenges, and navigates the complexity of privacy concerns, all while highlighting its transformative potential in the medical field. Our study primarily focuses on medical applications of \ac{FL}, particularly in the context of global cancer diagnosis. We highlight the potential of FL to enable computer-aided diagnosis tools that address this challenge with greater effectiveness than traditional data-driven methods. We hope that this comprehensive review will serve as a checkpoint for the field, summarizing the current state-of-the-art and identifying open problems and future research directions.

Machine learning and deep learning are two subsets of artificial intelligence that involve teaching computers to learn and make decisions from any sort of data. Most recent developments in artificial intelligence are coming from deep learning, which has proven revolutionary in almost all fields, from computer vision to health sciences. The effects of deep learning in medicine have changed the conventional ways of clinical application significantly. Although some sub-fields of medicine, such as pediatrics, have been relatively slow in receiving the critical benefits of deep learning, related research in pediatrics has started to accumulate to a significant level, too. Hence, in this paper, we review recently developed machine learning and deep learning-based solutions for neonatology applications. We systematically evaluate the roles of both classical machine learning and deep learning in neonatology applications, define the methodologies, including algorithmic developments, and describe the remaining challenges in the assessment of neonatal diseases by using PRISMA 2020 guidelines. To date, the primary areas of focus in neonatology regarding AI applications have included survival analysis, neuroimaging, analysis of vital parameters and biosignals, and retinopathy of prematurity diagnosis. We have categorically summarized 106 research articles from 1996 to 2022 and discussed their pros and cons, respectively. In this systematic review, we aimed to further enhance the comprehensiveness of the study. We also discuss possible directions for new AI models and the future of neonatology with the rising power of AI, suggesting roadmaps for the integration of AI into neonatal intensive care units.

Pediatric brain and spinal cancers remain the leading cause of cancer-related death in children. Advancements in clinical decision-support in pediatric neuro-oncology utilizing the wealth of radiology imaging data collected through standard care, however, has significantly lagged other domains. Such data is ripe for use with predictive analytics such as artificial intelligence (AI) methods, which require large datasets. To address this unmet need, we provide a multi-institutional, large-scale pediatric dataset of 23,101 multi-parametric MRI exams acquired through routine care for 1,526 brain tumor patients, as part of the Children's Brain Tumor Network. This includes longitudinal MRIs across various cancer diagnoses, with associated patient-level clinical information, digital pathology slides, as well as tissue genotype and omics data. To facilitate downstream analysis, treatment-na\"ive images for 370 subjects were processed and released through the NCI Childhood Cancer Data Initiative via the Cancer Data Service. Through ongoing efforts to continuously build these imaging repositories, our aim is to accelerate discovery and translational AI models with real-world data, to ultimately empower precision medicine for children.

Artificial intelligence (AI) methods hold immense potential to revolutionize numerous medical care by enhancing the experience of medical experts and patients. AI-based computer-assisted diagnosis and treatment tools can democratize healthcare by matching the clinical level or surpassing clinical experts. As a result, advanced healthcare services can be affordable to all populations, irrespective of demographics, race, or socioeconomic background. The democratization of such AI tools can reduce the cost of care, optimize resource allocation, and improve the quality of care. In contrast to humans, AI can uncover complex relations in the data from a large set of inputs and even lead to new evidence-based knowledge in medicine. However, integrating AI into healthcare raises several ethical and philosophical concerns, such as bias, transparency, autonomy, responsibility, and accountability. Here, we emphasize recent advances in AI-assisted medical image analysis, existing standards, and the significance of comprehending ethical issues and best practices for clinical settings. We cover the technical and ethical challenges and implications of deploying AI in hospitals and public organizations. We also discuss key measures and techniques to address ethical challenges, data scarcity, racial bias, lack of transparency, and algorithmic bias and provide recommendations and future directions.

Brain tumor segmentation is an active research area due to the difficulty in delineating highly complex shaped and textured tumors as well as the failure of the commonly used U-Net architectures. The combination of different neural architectures is among the mainstream research recently, particularly the combination of U-Net with Transformers because of their innate attention mechanism and pixel-wise labeling. Different from previous efforts, this paper proposes a novel network architecture that integrates Transformers into a self-adaptive U-Net to draw out 3D volumetric contexts with reasonable computational costs. We further add a residual connection to prevent degradation in information flow and explore ensemble methods, as the evaluated models have edges on different cases and sub-regions. On the BraTS 2021 dataset (3D), our model achieves 87.6% mean Dice score and outperforms the state-of-the-art methods, demonstrating the potential for combining multiple architectures to optimize brain tumor segmentation.